Cargando…

122: Assessment of the Usage of Hypofractionation for Prostate Cancer in an LMIC Before and After the COVID-19 Pandemic

Detalles Bibliográficos
Autores principales:	Asso, Rie, Patrocinio, Horacio, Ramia, Paul, Castilho, Marcos, Rosa, Arthur, Silva, Joao Luis, Cury, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ireland Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500566/ http://dx.doi.org/10.1016/S0167-8140(22)04401-2

Ejemplares similares

Practical considerations for prostate hypofractionation in the developing world
por: Yan, Michael, et al.
Publicado: (2021)

Better Care Through Hypofractionation
por: Boisvert-Huneault, Christian, et al.
Publicado: (2022)

SP-0140 Hypofractionation after Covid?
por: Cury, F.
Publicado: (2021)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Moderate hypofractionation for prostate cancer
por: Arcangeli, Stefano, et al.
Publicado: (2017)

Moderate hypofractionation for prostate cancer
por: Lee, W. Robert, et al.
Publicado: (2018)

Review of Hypofractionated Radiotherapy for Prostate Cancer
por: Spyropoulou, Despina, et al.
Publicado: (2012)

The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017)

Hypofractionation trials and radiobiology of prostate cancer
por: Gulliford, Sarah, et al.
Publicado: (2017)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
por: Cho, L. Chinsoo, et al.
Publicado: (2013)

Extreme Hypofractionation with SBRT in Localized Prostate Cancer
por: Gómez-Aparicio, Maria Antonia, et al.
Publicado: (2021)

Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey
por: Sabbagh, Ali, et al.
Publicado: (2023)

COVID-19 research in LMICs
por: Sisa, Ivan, et al.
Publicado: (2021)

Addressing an HIV cure in LMIC
por: Ismail, Sherazaan D., et al.
Publicado: (2021)

Is Aducanumab for LMICs? Promises and Challenges
por: Gunawardena, Illangage P. C., et al.
Publicado: (2021)

Advancing Tobacco Cessation in LMICs
por: Shankar, Abhishek, et al.
Publicado: (2022)

Intrafraction Prostate Motion Management for Ultra-Hypofractionated Radiotherapy of Prostate Cancer
por: Oehler, Christoph, et al.
Publicado: (2022)

Hypofractionation in Prostate Cancer: Radiobiological Basis and Clinical Appliance
por: Mangoni, M., et al.
Publicado: (2014)

Automated prediction of dosimetric eligibility for hypofractionated prostate radiotherapy
por: Lausch, Anthony, et al.
Publicado: (2017)

Evaluation of transperineal ultrasound imaging as a potential solution for target tracking during hypofractionated radiotherapy for prostate cancer
por: Han, Bin, et al.
Publicado: (2018)

Cancer drugs in LMICs: cheap but unaffordable
por: Gyawali, Bishal
Publicado: (2017)

Proton Therapy in LMICs: Is the Need Justified?
por: Chilukuri, Srinivas, et al.
Publicado: (2022)

Acute toxicity profile in prostate cancer with conventional and hypofractionated treatment
por: Viani, Gustavo Arruda, et al.
Publicado: (2013)

Evolution of Hypofractionated Accelerated Radiotherapy for Prostate Cancer – The Sunnybrook Experience
por: Musunuru, Hima Bindu, et al.
Publicado: (2014)

Prostate cancer and hypofractionation: really a new standard of care?
por: Carrie, Christian, et al.
Publicado: (2016)

Investigating the Benefit of Combined Androgen Modulation and Hypofractionation in Prostate Cancer
por: Zamagni, Alice, et al.
Publicado: (2020)

Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?
por: Mahase, Sean, et al.
Publicado: (2020)

Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in Africa
por: Swanson, William, et al.
Publicado: (2021)

Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation
por: Ha, Boram, et al.
Publicado: (2019)

Challenges of globalization of cancer drug trials- recruitment in LMICs, approval in HICs
por: Gyawali, Bishal, et al.
Publicado: (2021)

Point-of-care test for cervical cancer in LMICs
por: Mohammed, Sulma I., et al.
Publicado: (2016)

GeneXpert for the diagnosis of COVID-19 in LMICs
por: Rakotosamimanana, Niaina, et al.
Publicado: (2020)

Implementation research in LMICs—evolution through innovation
por: Sheikh, Kabir, et al.
Publicado: (2020)

COVID-19 in pregnancy: evidence from LMICs
por: Costa, Maria Laura, et al.
Publicado: (2022)

COVID-19 research in LMICs – Authors' reply
por: Torres, Irene, et al.
Publicado: (2021)

The need for COVID-19 clinical trials in LMICs
por: Saleh, Fatima
Publicado: (2023)

Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits
por: Ray, K.J., et al.
Publicado: (2015)

Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016)

Image-Guided Hypofractionated Radiotherapy in Low-Risk Prostate Cancer Patients
por: Valeriani, Maurizio, et al.
Publicado: (2014)

The Financial Impact of Hypofractionated Radiation for Localized Prostate Cancer in the United States
por: Moore, Assaf, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l4fpe3osist46ip3hu0q5cpgbl